New psychoactive substances: G8 statement on collection and sharing of data
Statement outlines the approaches to tackling challenges posed by NPS, covering the detection, analysis, identification, monitoring and reporting of synthetic drugs.
Documents
Details
New psychoactive substances (NPS) have changed the nature of the global drugs market. Substances that are not under international control, but mimic the effects of controlled substances, are now widely available.
G8 member states, the UN and the EU are committed to work together in developing a better understanding of NPS, and are committed to reducing the production, manufacture, distribution and demand for NPS.